1. Currarino G. Hajdu-Cheney syndrome associated with serpentine fibulae and polycystic kidney disease. Pediatr Radiol. 2009; 39:47–52.
2. Hajdu N, Kauntze R. Cranio-skeletal dysplasia. Br J Radiol. 1948; 21:42–48.
3. Cheney WD. Acro-osteolysis. Am J Roentgenol Radium Ther Nucl Med. 1965; 94:595–607.
4. Simpson MA, Irving MD, Asilmaz E, Gray MJ, Dafou D, Elmslie FV, Mansour S, Holder SE, Brain CE, Burton BK, et al. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet. 2011; 43:303–305.
5. Ornetti P, Tavernier C. Osteoporotic compression fracture revealing Hajdu-Cheney syndrome. Joint Bone Spine. 2012; 79:514–515.
6. Stathopoulos IP, Trovas G, Lampropoulou-Adamidou K, Koromila T, Kollia P, Papaioannou NA, Lyritis G. Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome. Bone. 2013; 52:366–371.
7. Han EJ, Mun JI, An SY, Jung YJ, Kim OH, Chung YS. A case report of Hajdu-Cheney syndrome. Endocrinol Metab. 2010; 25:152–156.
8. Narumi Y, Min BJ, Shimizu K, Kazukawa I, Sameshima K, Nakamura K, Kosho T, Rhee Y, Chung YS, Kim OH, et al. Clinical consequences in truncating mutations in exon 34 of NOTCH2: report of six patients with Hajdu-Cheney syndrome and a patient with serpentine fibula polycystic kidney syndrome. Am J Med Genet A. 2013; 161A:518–526.
9. Brennan AM, Pauli RM. Hajdu-Cheney syndrome: evolution of phenotype and clinical problems. Am J Med Genet. 2001; 100:292–310.
10. Zanotti S, Canalis E. Notch regulation of bone development and remodeling and related skeletal disorders. Calcif Tissue Int. 2012; 90:69–75.
11. Kung AW, Xiao SM, Cherny S, Li GH, Gao Y, Tso G, Lau KS, Luk KD, Liu JM, Cui B, et al. Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am J Hum Genet. 2010; 86:229–239.
12. McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, Spinner NB. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet. 2006; 79:169–173.
13. Majewski J, Schwartzentruber JA, Caqueret A, Patry L, Marcadier J, Fryns JP, Boycott KM, Ste-Marie LG, McKiernan FE, Marik I, et al. FORGE Canada Consortium. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome. Hum Mutat. 2011; 32:1114–1117.
14. Ninov N, Borius M, Stainier DY. Different levels of Notch signaling regulate quiescence, renewal and differentiation in pancreatic endocrine progenitors. Development. 2012; 139:1557–1567.
15. Lammert E, Brown J, Melton DA. Notch gene expression during pancreatic organogenesis. Mech Dev. 2000; 94:199–203.
16. Li HJ, Kapoor A, Giel-Moloney M, Rindi G, Leiter AB. Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine. Dev Biol. 2012; 371:156–169.
17. Afelik S, Qu X, Hasrouni E, Bukys MA, Deering T, Nieuwoudt S, Rogers W, Macdonald RJ, Jensen J. Notch-mediated patterning and cell fate allocation of pancreatic progenitor cells. Development. 2012; 139:1744–1753.
18. Bar Y, Russ HA, Sintov E, Anker-Kitai L, Knoller S, Efrat S. Redifferentiation of expanded human pancreatic β-cell-derived cells by inhibition of the NOTCH pathway. J Biol Chem. 2012; 287:17269–17280.